Author

R. Shemer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Evolutionary Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

Y. Dor· 2 shared A. Jarjoui· 1 shared A. Livnat· 1 shared A. Malik· 1 shared A. Quteineh· 1 shared A. Rokach· 1 shared B. Glaser· 1 shared C. Chen-Shuali· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Y. Dor

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Epigenetic liquid biopsies reveal elevated vascular endothelial cell turnover and erythropoiesis in asymptomatic COVID-19 patients

R. Ben Ami, N. Loyfer, E. Cohn, G. Fialkoff, I. Sharkia, N. Bogot, D. Kochan, G. Kalak, A. Jarjoui, C. Chen-Shuali, H. Azulai, H. Barhoum, N. Arish, M. M. Greenberger, D. Velleman, , Y. Dor

This study uses epigenetic liquid biopsies to show that asymptomatic COVID-19 patients have elevated vascular endothelial cell and erythroblast turnover, indicating sub-clinical vascular and erythrocyte damage.

bioRxiv · Jul 28, 2023 · PreprintMicrobiology

Development of methylation-based biomarkers for breast cancer detection by model training and validation in synthetic cell-free DNA

S. M. de Proce, M. Adamowicz, P. Dutta, S. J. Warlow, J. Moss, R. Shemer, Y. Dor, C. Robert, T. J. Aitman

This study develops methylation-based biomarkers for breast cancer detection using synthetic cell-free DNA and validates their performance with in vitro testing.

bioRxiv · Feb 11, 2022 · PreprintCancer Biology

De novo mutation rates at the single-mutation resolution in a human HBB gene-region associated with adaptation and genetic disease

D. Melamed, Y. Nov, A. Malik, M. B. Yakass, E. Bolotin, R. Shemer, E. K. Hiadzi, K. L. Skorecki, A. Livnat

The paper measures de novo mutation rates at single-mutation resolution in a human HBB gene region, finding higher rates in Africans and significant variation in specific mutations.

bioRxiv · May 24, 2021Evolutionary Biology